Kevin Pacheco Barrios, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phantom Limb | 9 | 2024 | 96 | 3.720 |
Why?
|
Motor Cortex | 11 | 2024 | 995 | 2.580 |
Why?
|
Diabetic Neuropathies | 3 | 2024 | 406 | 1.420 |
Why?
|
Fibromyalgia | 6 | 2024 | 401 | 1.400 |
Why?
|
Transcranial Magnetic Stimulation | 10 | 2024 | 1469 | 1.280 |
Why?
|
Vagus Nerve Stimulation | 3 | 2024 | 224 | 1.050 |
Why?
|
Theta Rhythm | 2 | 2024 | 217 | 0.990 |
Why?
|
Latin America | 6 | 2023 | 404 | 0.970 |
Why?
|
Neck Pain | 1 | 2024 | 186 | 0.810 |
Why?
|
Tuberculosis, Central Nervous System | 1 | 2022 | 16 | 0.810 |
Why?
|
Tuberculosis, Meningeal | 1 | 2022 | 47 | 0.780 |
Why?
|
Tension-Type Headache | 1 | 2023 | 76 | 0.770 |
Why?
|
Exercise Therapy | 4 | 2024 | 919 | 0.740 |
Why?
|
Spinal Cord Ischemia | 1 | 2021 | 94 | 0.710 |
Why?
|
Guillain-Barre Syndrome | 1 | 2021 | 125 | 0.690 |
Why?
|
Neurocysticercosis | 1 | 2021 | 91 | 0.670 |
Why?
|
Spinal Cord Injuries | 3 | 2022 | 924 | 0.660 |
Why?
|
Quality-Adjusted Life Years | 7 | 2024 | 1724 | 0.650 |
Why?
|
Spinal Cord Diseases | 1 | 2021 | 293 | 0.630 |
Why?
|
Caribbean Region | 3 | 2023 | 190 | 0.570 |
Why?
|
Evoked Potentials, Motor | 5 | 2024 | 461 | 0.560 |
Why?
|
Memory Disorders | 1 | 2024 | 1197 | 0.560 |
Why?
|
Beta Rhythm | 3 | 2022 | 63 | 0.560 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 3 | 2024 | 170 | 0.530 |
Why?
|
Communicable Diseases | 1 | 2024 | 878 | 0.510 |
Why?
|
Sports | 1 | 2021 | 700 | 0.500 |
Why?
|
Lower Extremity | 3 | 2024 | 1194 | 0.460 |
Why?
|
Functional Laterality | 1 | 2020 | 2253 | 0.440 |
Why?
|
Migraine Disorders | 2 | 2023 | 1693 | 0.430 |
Why?
|
Cerebral Hemorrhage | 2 | 2022 | 2660 | 0.420 |
Why?
|
Peru | 7 | 2023 | 869 | 0.420 |
Why?
|
Osteoarthritis, Knee | 4 | 2023 | 1234 | 0.400 |
Why?
|
Premature Birth | 1 | 2024 | 1771 | 0.390 |
Why?
|
Patient Discharge | 2 | 2022 | 3476 | 0.390 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2061 | 0.370 |
Why?
|
Mycobacterium tuberculosis | 1 | 2022 | 1903 | 0.370 |
Why?
|
Population Surveillance | 1 | 2021 | 2608 | 0.350 |
Why?
|
Mental Disorders | 4 | 2024 | 6796 | 0.350 |
Why?
|
Humans | 76 | 2024 | 760621 | 0.340 |
Why?
|
Epilepsy | 2 | 2024 | 3267 | 0.330 |
Why?
|
Electroencephalography | 8 | 2024 | 6189 | 0.330 |
Why?
|
Antipsychotic Agents | 1 | 2022 | 3061 | 0.320 |
Why?
|
Depression | 3 | 2024 | 8044 | 0.310 |
Why?
|
Brain | 9 | 2024 | 26951 | 0.300 |
Why?
|
Stroke | 4 | 2024 | 9962 | 0.280 |
Why?
|
Morbidity | 2 | 2022 | 1765 | 0.260 |
Why?
|
Cross-Sectional Studies | 14 | 2024 | 25942 | 0.240 |
Why?
|
Pain Threshold | 3 | 2023 | 603 | 0.240 |
Why?
|
Pain | 7 | 2024 | 5066 | 0.240 |
Why?
|
Models, Biological | 1 | 2020 | 9467 | 0.230 |
Why?
|
Pain Measurement | 7 | 2022 | 3528 | 0.230 |
Why?
|
Neuralgia | 2 | 2020 | 600 | 0.220 |
Why?
|
Incidence | 4 | 2024 | 21392 | 0.220 |
Why?
|
Amputees | 2 | 2020 | 86 | 0.210 |
Why?
|
Adult | 24 | 2024 | 219994 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.210 |
Why?
|
Prevalence | 4 | 2023 | 15687 | 0.210 |
Why?
|
Life Expectancy | 3 | 2024 | 1248 | 0.200 |
Why?
|
Female | 28 | 2024 | 391270 | 0.200 |
Why?
|
Brain Diseases | 2 | 2021 | 1540 | 0.190 |
Why?
|
Pandemics | 2 | 2023 | 8624 | 0.190 |
Why?
|
Alpha Rhythm | 1 | 2021 | 109 | 0.190 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2021 | 68 | 0.180 |
Why?
|
Young Adult | 11 | 2024 | 58741 | 0.180 |
Why?
|
Resistance Training | 1 | 2023 | 185 | 0.180 |
Why?
|
Tuberculoma, Intracranial | 1 | 2020 | 8 | 0.180 |
Why?
|
Hypertension | 1 | 2021 | 8594 | 0.180 |
Why?
|
Neuronal Plasticity | 3 | 2024 | 1430 | 0.180 |
Why?
|
Dementia, Vascular | 1 | 2021 | 123 | 0.170 |
Why?
|
Parturition | 1 | 2023 | 446 | 0.170 |
Why?
|
Male | 22 | 2024 | 359744 | 0.170 |
Why?
|
Stuttering | 1 | 2019 | 25 | 0.170 |
Why?
|
Speech Production Measurement | 1 | 2019 | 96 | 0.160 |
Why?
|
Postural Balance | 1 | 2024 | 617 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2024 | 10344 | 0.160 |
Why?
|
Animal Assisted Therapy | 1 | 2019 | 13 | 0.160 |
Why?
|
Asia | 1 | 2020 | 620 | 0.160 |
Why?
|
Bayes Theorem | 2 | 2024 | 2326 | 0.160 |
Why?
|
Population Dynamics | 1 | 2020 | 306 | 0.150 |
Why?
|
General Practitioners | 1 | 2019 | 102 | 0.150 |
Why?
|
Africa | 1 | 2020 | 705 | 0.150 |
Why?
|
Endovascular Procedures | 2 | 2022 | 2165 | 0.150 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2024 | 553 | 0.150 |
Why?
|
Urban Health | 1 | 2020 | 533 | 0.150 |
Why?
|
Headache | 2 | 2023 | 1249 | 0.150 |
Why?
|
Neural Inhibition | 1 | 2021 | 589 | 0.150 |
Why?
|
Arthralgia | 1 | 2022 | 461 | 0.150 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 893 | 0.140 |
Why?
|
Cannabis | 1 | 2023 | 436 | 0.140 |
Why?
|
Somatosensory Cortex | 1 | 2020 | 511 | 0.130 |
Why?
|
Choice Behavior | 1 | 2022 | 821 | 0.130 |
Why?
|
Multiple Sclerosis | 1 | 2021 | 3204 | 0.130 |
Why?
|
Imagination | 1 | 2017 | 226 | 0.130 |
Why?
|
Nerve Block | 1 | 2022 | 688 | 0.130 |
Why?
|
HIV Infections | 1 | 2022 | 17165 | 0.130 |
Why?
|
Respiratory Tract Infections | 1 | 2023 | 1007 | 0.130 |
Why?
|
Patient Care Planning | 1 | 2021 | 908 | 0.120 |
Why?
|
Patient Participation | 1 | 2024 | 1439 | 0.120 |
Why?
|
Patient Preference | 1 | 2022 | 922 | 0.120 |
Why?
|
Chronic Disease | 1 | 2020 | 9287 | 0.120 |
Why?
|
Gait | 1 | 2020 | 812 | 0.120 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2023 | 1079 | 0.110 |
Why?
|
Middle Aged | 14 | 2024 | 220352 | 0.110 |
Why?
|
Home Care Services | 1 | 2020 | 654 | 0.110 |
Why?
|
Self Concept | 1 | 2019 | 1039 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7475 | 0.110 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2020 | 831 | 0.110 |
Why?
|
Low Back Pain | 1 | 2022 | 979 | 0.110 |
Why?
|
Cause of Death | 1 | 2024 | 3725 | 0.110 |
Why?
|
Primary Health Care | 1 | 2020 | 4647 | 0.110 |
Why?
|
Risk Factors | 4 | 2024 | 74359 | 0.110 |
Why?
|
Exercise | 3 | 2024 | 5787 | 0.110 |
Why?
|
Aged | 10 | 2024 | 169152 | 0.110 |
Why?
|
Biosensing Techniques | 1 | 2019 | 677 | 0.110 |
Why?
|
Respiration | 1 | 2019 | 1654 | 0.100 |
Why?
|
Embolization, Therapeutic | 1 | 2022 | 1413 | 0.100 |
Why?
|
Intracranial Aneurysm | 1 | 2022 | 1276 | 0.100 |
Why?
|
Evidence-Based Medicine | 2 | 2021 | 3696 | 0.100 |
Why?
|
Extremities | 1 | 2017 | 867 | 0.100 |
Why?
|
Antitubercular Agents | 1 | 2020 | 1373 | 0.100 |
Why?
|
Forecasting | 1 | 2020 | 2932 | 0.090 |
Why?
|
Glucocorticoids | 1 | 2020 | 2145 | 0.090 |
Why?
|
Vagus Nerve | 2 | 2024 | 458 | 0.090 |
Why?
|
Disabled Persons | 1 | 2020 | 1223 | 0.090 |
Why?
|
Disease Management | 1 | 2021 | 2514 | 0.090 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2017 | 1489 | 0.090 |
Why?
|
Recovery of Function | 1 | 2020 | 2985 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1647 | 0.080 |
Why?
|
Brazil | 2 | 2024 | 1218 | 0.080 |
Why?
|
Mortality | 1 | 2020 | 2916 | 0.080 |
Why?
|
Parkinson Disease | 1 | 2023 | 2859 | 0.080 |
Why?
|
Prospective Studies | 6 | 2024 | 54303 | 0.080 |
Why?
|
Brain Ischemia | 1 | 2022 | 3127 | 0.080 |
Why?
|
Brain Mapping | 2 | 2021 | 6568 | 0.080 |
Why?
|
Rest | 2 | 2024 | 914 | 0.080 |
Why?
|
Hospitals | 1 | 2021 | 3928 | 0.070 |
Why?
|
Health Status | 1 | 2021 | 4081 | 0.070 |
Why?
|
Decision Making | 1 | 2021 | 3925 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3224 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2022 | 4925 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 36290 | 0.070 |
Why?
|
Disease Progression | 1 | 2024 | 13502 | 0.070 |
Why?
|
Infant, Newborn | 2 | 2024 | 26181 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2022 | 14660 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 2023 | 4371 | 0.070 |
Why?
|
Risk Assessment | 2 | 2024 | 24123 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2023 | 4555 | 0.060 |
Why?
|
Combined Modality Therapy | 3 | 2024 | 8552 | 0.060 |
Why?
|
Blood Pressure | 1 | 2021 | 8525 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3018 | 0.060 |
Why?
|
Treatment Outcome | 8 | 2024 | 65017 | 0.060 |
Why?
|
Dementia | 1 | 2019 | 2649 | 0.060 |
Why?
|
Cognition | 4 | 2024 | 6957 | 0.060 |
Why?
|
Clinical Competence | 1 | 2019 | 4783 | 0.060 |
Why?
|
Europe | 1 | 2020 | 3441 | 0.050 |
Why?
|
Bipolar Disorder | 1 | 2020 | 5078 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2024 | 8547 | 0.050 |
Why?
|
Cortical Synchronization | 1 | 2022 | 77 | 0.050 |
Why?
|
Retrospective Studies | 2 | 2021 | 80372 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2021 | 12427 | 0.050 |
Why?
|
Amphetamines | 1 | 2023 | 143 | 0.050 |
Why?
|
Bundle-Branch Block | 1 | 2024 | 281 | 0.050 |
Why?
|
Heart Rate | 2 | 2024 | 4179 | 0.050 |
Why?
|
Gait Disorders, Neurologic | 1 | 2024 | 238 | 0.050 |
Why?
|
Oscillometry | 1 | 2021 | 145 | 0.050 |
Why?
|
Vertebral Artery | 1 | 2022 | 185 | 0.050 |
Why?
|
Adolescent | 3 | 2024 | 87810 | 0.050 |
Why?
|
Ethambutol | 1 | 2020 | 59 | 0.040 |
Why?
|
Pain Perception | 1 | 2022 | 196 | 0.040 |
Why?
|
Prefrontal Cortex | 2 | 2021 | 2212 | 0.040 |
Why?
|
Pyrazinamide | 1 | 2020 | 60 | 0.040 |
Why?
|
Immunocompetence | 1 | 2020 | 138 | 0.040 |
Why?
|
Methylprednisolone | 1 | 2021 | 384 | 0.040 |
Why?
|
Heart Failure | 1 | 2024 | 11847 | 0.040 |
Why?
|
Neuropsychological Tests | 2 | 2024 | 7021 | 0.040 |
Why?
|
Finite Element Analysis | 1 | 2021 | 428 | 0.040 |
Why?
|
Nystagmus, Pathologic | 1 | 2020 | 105 | 0.040 |
Why?
|
Endemic Diseases | 1 | 2020 | 190 | 0.040 |
Why?
|
Sensation | 1 | 2021 | 331 | 0.040 |
Why?
|
Cerebellar Ataxia | 1 | 2020 | 149 | 0.040 |
Why?
|
Autonomic Nervous System | 1 | 2024 | 697 | 0.040 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2024 | 741 | 0.040 |
Why?
|
Quality of Life | 4 | 2022 | 13308 | 0.040 |
Why?
|
Isoniazid | 1 | 2020 | 283 | 0.040 |
Why?
|
Quadriplegia | 1 | 2020 | 226 | 0.040 |
Why?
|
Rifampin | 1 | 2020 | 340 | 0.040 |
Why?
|
Muscle Contraction | 1 | 2022 | 1201 | 0.040 |
Why?
|
Electric Stimulation | 1 | 2022 | 1735 | 0.040 |
Why?
|
Electromyography | 1 | 2022 | 1388 | 0.040 |
Why?
|
Thrombectomy | 1 | 2022 | 708 | 0.040 |
Why?
|
Nausea | 1 | 2020 | 678 | 0.040 |
Why?
|
Vomiting | 1 | 2020 | 650 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5508 | 0.030 |
Why?
|
Intracranial Hemorrhages | 1 | 2022 | 844 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1544 | 0.030 |
Why?
|
Blindness | 1 | 2020 | 582 | 0.030 |
Why?
|
Analgesics | 1 | 2022 | 1065 | 0.030 |
Why?
|
Evoked Potentials | 1 | 2021 | 1036 | 0.030 |
Why?
|
Reading | 1 | 2019 | 529 | 0.030 |
Why?
|
Perfusion | 1 | 2020 | 1376 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2022 | 1001 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2022 | 1803 | 0.030 |
Why?
|
Speech | 1 | 2019 | 550 | 0.030 |
Why?
|
Motor Activity | 1 | 2024 | 2687 | 0.030 |
Why?
|
Dogs | 1 | 2019 | 3841 | 0.030 |
Why?
|
Models, Neurological | 1 | 2021 | 1758 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2022 | 1869 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2022 | 2108 | 0.030 |
Why?
|
Walking | 1 | 2020 | 1189 | 0.030 |
Why?
|
Dexamethasone | 1 | 2020 | 1927 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3113 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3215 | 0.030 |
Why?
|
Patient Selection | 1 | 2024 | 4283 | 0.020 |
Why?
|
Animals | 2 | 2021 | 167963 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2001 | 0.020 |
Why?
|
Seizures | 1 | 2024 | 2917 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 41335 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 7806 | 0.020 |
Why?
|
Stroke Volume | 1 | 2024 | 5523 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6498 | 0.020 |
Why?
|
Survival Rate | 1 | 2024 | 12808 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8555 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 58995 | 0.020 |
Why?
|
Sleep | 1 | 2023 | 4751 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12159 | 0.020 |
Why?
|
Research Design | 1 | 2022 | 6180 | 0.020 |
Why?
|
Hospitalization | 1 | 2024 | 10790 | 0.010 |
Why?
|
Anxiety | 1 | 2019 | 4538 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15840 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29749 | 0.010 |
Why?
|
Infant | 1 | 2023 | 36060 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 42063 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39261 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20509 | 0.010 |
Why?
|
United States | 1 | 2024 | 72461 | 0.010 |
Why?
|